ArticleLeukemia2011
Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia.
S Mizuta et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
45 papers cite it
this paperpooled ittrialcites it